JYONG BIOTECH LTDMENS
ASignal's systematic analysis rates MENS as Bearish.
Reflects the latest available analysis · analyzed Oct 18, 2026
The case on MENS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Free cash flow positive at $4.39M
- Low enterprise value relative to negative EV/EBITDA multiple
- Price near lower Bollinger Band, suggesting potential mean reversion
- Negative operating cash flow of $-3.04M
- Extremely weak liquidity with quick ratio of 0.03x
- Negative return on assets (-12.01%)
- Negative price-to-book ratio indicating negative equity
- High debt levels relative to cash
- Bearish MACD histogram trending downward
See the full verdict on MENS
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MENS
Most investors never get a second opinion, let alone several. ASignal runs MENS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.